US 10138228
Isoxazole derivatives as FXR agonists and methods of use therof
granted A61KA61K31/42
Quick answer
US patent 10138228 (Isoxazole derivatives as FXR agonists and methods of use therof) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/42